Daiichi Sankyo to acquire Zepharma from Astellas

TOKYO, Japan - Takashi Shoda (R), president of Daiichi Sankyo Co., and Masaji Oe, president of Zepharma Inc., stellas Pharma Inc.'s nonprescription drug unit, shake hands at a news conference at Daiichi Sankyo's head office in Tokyo on March 31. They announced Daiichi Sankyo will buy Zepharma for 23.5 billion yen.

Sample
PDF Preview

Product Code
ILEA001114314

Registered date
2006/3/31 00:00:00

Credit
Kyodo / Kyodo News Images

Media source
2006 Kyodo News

Media size
1864 × 1228 pixel

Resolution
dpi

Deployment size
476.61(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

Oracle to invest $8 bil. in Japan

U.S. IT firm Oracle Corp. CEO Safra Catz holds a press conference in Tokyo on April 18, 2024. She said the Japanese unit of Oracle Corp. will invest $8 billion in Japan over the next 10 years to respond to the country's growing demand for cloud computing and artificial intelligence.

Oracle to invest $8 bil. in Japan

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi speaks at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (C) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (2nd from L) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (R) apologizes at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

Kobayashi Pharma shareholders' meeting in Osaka

A Kobayashi Pharmaceutical Co. shareholder (R) speaks to reporters ahead of the company's annual shareholders' meeting in the western Japan city of Osaka on March 28, 2024. The company said it has confirmed two more deaths linked to the consumption of its red yeast rice dietary supplements which had already been implicated in two other deaths from kidney-related conditions and over 100 hospitalizations.

Translator earphones in shape of Japanese popular snack

A woman holds a wireless translator earphone (L) shaped to look like the popular Japanese chocolate snack "Kinoko no Yama" produced by Meiji Holdings Co. next to the real snack (R) on March 25, 2024, in Narita, Chiba Prefecture, near Tokyo. The earphones are capable of translating 74 languages and will hit the shelves later in the week at the price of 29,800 yen ($190).

Japan Automobile Manufacturers Association, Inc. Conference

Japan Automobile Manufacturers Association, Inc. Conference. Makoto Uchida, Director, Representative Executive Officer, President and Chief Executive Officer, Nissan Motor Co. =Date:March 22, 2024, Place: Tokyo

Japan Automobile Manufacturers Association, Inc. Conference

Japan Automobile Manufacturers Association, Inc. Conference. Yoshihiro Hidaka President and Chief Executive Officer, Yamaha Motor Co. =Date:March 22, 2024, Place: Tokyo